Therapeutic potential of mesenchymal stem cells for oral and systemic diseases
- PMID: 22835544
- PMCID: PMC3426923
- DOI: 10.1016/j.cden.2012.05.006
Therapeutic potential of mesenchymal stem cells for oral and systemic diseases
Abstract
Mesenchymal stem cells (MSCs) are adult stem cells whose self-renewal, multipotency, and immunosuppressive functions have been investigated for therapeutic applications. MSCs have used for various systemic organ regenerative therapies, allowing rescue of tissue function in damaged or failing organs. This article reviews the regenerative and immunomodulatory functions of MSCs and their applications in dental, orofacial, and systemic tissue regeneration and treatment of inflammatory disorders. It also addresses challenges to MSC-mediated therapeutics arising from tissue and MSC aging and host immune response against allogenic MSC transplantation, and discusses alternative sources of MSCs aimed at overcoming these limitations.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures
References
-
- Kode JA, Mukherjee S, Joglekar MV, et al. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cryother. 2009;1:377–391. - PubMed
-
- Friedenstein AJ, Piatetzky-Shapiro I, Petrakova KV. Osteogenesis in transplants of bone marrow cells. Embryol Exp Morph. 1966;16:381–390. - PubMed
-
- Yang S, Huang S, Feng C, et al. Umbilical cord-derived mesenchymal stem cells: strategies, challenges, and potential for cutaneous regeneration. Front Med. 2012;6:41–47. - PubMed
-
- Gonzalez RE, Gonzalez MA, Varela N, et al. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cellsin vitroin rheumatoid arthritis. Ann Rheum Dis. 2010;69:241–248. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
